Atlas market file · Equity · United States
Interparfums IncIPAR
- Last close
- 119.00
- Change
- -3.54%
- 96-bar range
- 85.62 – 129.29
- As of
- 6 Aug 2026
Interparfums Inc is a perfumes, cosmetics & other toilet preparations issuer listed as IPAR on NASDAQ. Use this page to check the price chart, company context, source-backed updates, risks and evidence before opening the full Atlas research file.
- Identity
- Nasdaq Trader
- Chart rail
- TradingView
- File state
- Public profile
Static Daily candlestick snapshot from the approved cache, drawn on a labelled price axis: green bodies closed up, red closed down, wicks span each bar's high-to-low range. The live TradingView link stays available; the public profile never embeds a widget that can render the wrong symbol.
▮ up candle ▮ down candle
Weekly outlook: the last 104 weekly closes (-5.30% over the window).
Source rail: Yahoo Finance chart API (IPAR). This dated snapshot is the crawlable Atlas reference.
Live market viewTradingView · provider feed Open view ->
Open the attributed TradingView market view for IPAR. The dated Atlas snapshot above remains the crawlable reference; exchange data in this panel may be live or delayed as labelled by TradingView.
IPAR public profile
Perfumes, cosmetics & other toilet preparations issuer. Interparfums Inc is connected to current market context, cited company sources and its retained research file.
Interparfums Inc trades as IPAR on NASDAQ. Interparfums Inc (IPAR) has a latest verified close of 119.00, down 3.54%, dated 6 Aug 2026.
Open the chart, inspect attributed company evidence and continue into the fuller research file without losing this market context. Atlas files IPAR under USA Stocks for browsing.
What changed for Interparfums Inc today
Inter Parfums, Inc. (IPAR), the perfume house behind DKNY, MCM, and the newly acquired Goutal Paris, just showed the world what a luxury fragrance company looks like when the cash flow report arrives with a side order of awkward silence. The last 10-Q, filed on 5 May 2026, lists $1.54 billion of total assets, $881.6 million of shareholders’ equity, and a tidy $43.4 million of net income for the quarter ending 31 March 2026. Yet the same document quietly records that operating cash flow for the period was a mere $85,000, down from what one might expect for a fragrance firm with $1.45 billion of annual sales guidance. Inventory, meanwhile, has swollen by $24.4 million to $369.6 million, suggesting bottles are stacking up while the cash conversion stumbles. The board may still believe in the scent of future cash, but the balance sheet is currently holding its breath.
What Inter Parfums actually does is licence, create, produce and distribute prestige fragrances under global brands such as DKNY and MCM, and, since March 2025, under the Goutal Paris banner after acquiring the intellectual property from Amorepacific Europe. The company’s French subsidiary, Interparfums SA, also signed an exclusive licence with Longchamp in July 2025, giving it control over fragrance lines for the Parisian maison until 31 December 2036. The brand portfolio is undeniably polished, but the operating cash flow for the quarter ending March 2026 suggests the scent of real cash is still on the horizon. The company’s cash-rich presentation page shows DKNY and MCM as modern, confident icons, yet the audited cash numbers read like a fragrance ad where the real top note is vapour.
The financials, as filed, are precise but unflattering. Operating income was $74.1 million for the quarter, net income $43.4 million, and diluted EPS $1.35 on 32.0 million weighted average shares. Short-term investments clock in at $157.2 million, but the company only generated $85,000 from operating activities, while spending $1.4 million on property, plant and equipment. The inventory build of $24.4 million is the clearest sign yet that the company is producing scent at scale but collecting cash at a cautious trot. Guidance reaffirmed in April 2026 still targets $1.45 billion of net sales and $5.15 of earnings per diluted share for 2025, but the cash conversion story is the one part of the bottle that hasn’t been filled yet.
The official product pages for DKNY and MCM present the brands as modern, confident icons rooted in New York and German heritage respectively, complete with stylised images that sell lifestyle and attitude. The Goutal Paris page quietly confirms the March 2025 acquisition of all intellectual property rights by Interparfums SA. These pages prove the marketing story is strong, but they do not prove the cash conversion story is equally robust. The SEC filings, by contrast, show a company with robust brand equity but a cash flow that is still learning to exhale. The scent of success is present in the brand portfolio, but the cash register’s melody is still a work in progress.
Inter Parfums’ 8-Ks since April 2026 confirm that management is sticking to its 2025 guidance and extending its licence runway-Longchamp to 2036 and Goutal Paris under permanent control. Yet the cash flow line for the quarter ending March 2026 remains the elephant in the scent shop: $85,000 of operating cash flow against $24.4 million of inventory growth. The company’s cash-rich presentation and polished brand pages are not evidence of cash conversion; they are evidence of a company that knows how to sell stories, but still needs to sell the scent of real cash. The next time the board meets, it may need to ask whether the licence agreements are priced for profit or merely for prestige. The evidence so far suggests the latter.
If Inter Parfums wants to turn its scent portfolio into a cash engine, the next 10-Q must show operating cash flow rising above the rent of a Midtown Manhattan perfume counter. Until then, the balance sheet smells faintly of potential, but the nose knows: potential is not cash. The product pages are beautiful; the cash page is still waiting for its eau de conversion.
Sources & evidence · 10 links
This is the public answer layer. The full Atlas report adds the complete Market Wit archive, risk rail, catalyst map, final editor synthesis, PDF/CSV export, email delivery and saved history.
IPAR technical readout
Directional bias up. Wilder ADX and ATR computed from Atlas approved daily OHLC through 2026-07-28. Indicators are descriptive statistics, not investment advice.
Open an Atlas research path on IPAR
FreedomCore Atlas can expand this public profile into source-led research files with company snapshots, valuation context, filings and segment detail, source packs, and equity briefs. Each path keeps the underlying public sources visible.
Open Atlas workstation ->Keep IPAR research in your Atlas archive
Free Atlas includes the public profile and one owned welcome research artifact after account setup. Atlas Pro adds up to 25 custom research runs a day, a 500-symbol watchlist, saved report versions, and eligible PDF, CSV, and email artifacts. Evidence holds still apply and never become an unverified download. £12/month founding price, locked for life. Research only; not investment advice.
Checking Atlas access...
IPAR FAQ
What is Interparfums Inc (IPAR)?Interparfums Inc (IPAR) has a latest verified close of 119.00, down 3.54%, dated 6 Aug 2026. Use this page to check the price chart, company context, source-backed...
Interparfums Inc (IPAR) has a latest verified close of 119.00, down 3.54%, dated 6 Aug 2026. Use this page to check the price chart, company context, source-backed updates, risks and evidence before opening the full Atlas research file.
What does Atlas show for IPAR?Interparfums Inc (IPAR) has a latest verified close of 119.00, down 3.54%, dated 6 Aug 2026. It brings the latest available chart, company context, cited sources, risks...
Interparfums Inc (IPAR) has a latest verified close of 119.00, down 3.54%, dated 6 Aug 2026. It brings the latest available chart, company context, cited sources, risks and the route into the full Atlas research file together. Atlas files IPAR under USA Stocks for browsing.
How often is the IPAR page updated?The IPAR public file is refreshed when a newer verified market bar, company filing, official release or material source update is available. The visible date shows the...
The IPAR public file is refreshed when a newer verified market bar, company filing, official release or material source update is available. The visible date shows the freshness of the current market snapshot.
Which sources does Atlas use for IPAR?The IPAR file starts with SEC EDGAR filings, Nasdaq Trader and TradingView NASDAQ:IPAR. SEC EDGAR provides the filing anchor for this issuer. The page separates...
The IPAR file starts with SEC EDGAR filings, Nasdaq Trader and TradingView NASDAQ:IPAR. SEC EDGAR provides the filing anchor for this issuer. The page separates verified market context from company evidence and shows open evidence gaps instead of filling them with assumptions.
Can Atlas run a full research brief on IPAR?Yes. The workstation can open IPAR, expand the public source set into a fuller browser report, and add email, PDF or CSV export where the account tier allows it.
Yes. The workstation can open IPAR, expand the public source set into a fuller browser report, and add email, PDF or CSV export where the account tier allows it.
Is this IPAR page investment advice?No. The IPAR page is a research and source-navigation page. It does not provide personalised financial advice, brokerage execution, a trading instruction, or a promise...
No. The IPAR page is a research and source-navigation page. It does not provide personalised financial advice, brokerage execution, a trading instruction, or a promise of returns.
Methodology
This profile is generated daily from public sources including SEC EDGAR (US-listed companies), NASDAQ Trader files, exchange listings, public macro/central-bank releases, CoinGecko crypto market files where relevant, and the TradingView global symbol catalog. Multi-model AI may assist drafting and review where configured, but sources remain the evidence rail; the chart is an Atlas static OHLC rail with a live TradingView link when verified bars are available; otherwise the page keeps the verified TradingView route as an explicit fallback.
Research only. Not investment advice. No brokerage execution. No guaranteed returns are promised or implied. FreedomCore does not provide personalised investment advice. Always consult a regulated financial advisor before making investment decisions.
Profile last updated: 2026-08-07. Browse FreedomCore Atlas research notes →
IPAR
Equity · evidence first